InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000079 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28 MET Khalaf Michel Pres, CEO, Dir A - Grant — +260.3K 524.9K +98% —
DM 2023-03-02 2023-02-28+ MET Khalaf Michel Pres, CEO, Dir F - Tax $71.68 -143.6K 381.3K -27% -$10.29M
D 2023-03-02 2023-02-28 MET Khalaf Michel Pres, CEO, Dir A - Grant $0.00 +91.0K 91.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-28 A A 30,323 — 294,941 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
2 Common Common Stock 2023-02-28 F D 127,023 $71.73 397,868 D — —
3 Common Common Stock 2023-03-01 F D 16,602 $71.27 381,266 D — —
4 Common Common Stock 2023-02-28 A A 229,950 — 524,891 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 90,967 $0.00 90,967 D $71.73 · — to 2033-02-27 90,967 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.